Kalii Chloridum + Glucosum Kabi

Potassium chloride, the active ingredient in Kalii Chloridum + Glucosum Kabi, is an electrolyte supplement presented as a solution for injection for intravenous use. It is used to correct low blood potassium levels and, together with glucose, supports cellular energy metabolism in patients requiring rapid electrolyte and glucose replacement.

GNH USA supplies Kalii Chloridum + Glucosum Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Kalii Chloridum + Glucosum Kabi is employed in clinical situations that involve electrolyte and glucose deficits. - Hypokalemia: restores normal serum potassium concentrations. - Potassium supplementation: provides potassium ions during peri‑operative or critical‑care management. - Hypoglycemia: delivers glucose to raise blood sugar quickly. - Fluid and electrolyte replacement: contributes to overall electrolyte balance in patients receiving intravenous therapy.

Adverse reactions may occur with intravenous administration of potassium chloride and glucose solutions.

Common Side Effects: - Injection site pain: discomfort at the infusion site. - Hyperkalemia: elevated serum potassium if over‑infused. - Hyperglycemia: transient rise in blood glucose levels. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm due to potassium shifts. - Anaphylactic reaction: severe allergic response requiring emergency care. - Severe hyperkalemia leading to muscle weakness or paralysis.

Use of Kalii Chloridum + Glucosum Kabi requires careful clinical assessment. - Renal impairment: monitor serum potassium closely. - Cardiac disease: watch for arrhythmias during infusion. - Diabetes mellitus: observe blood glucose levels. - Concomitant potassium‑sparing drugs: increased risk of hyperkalemia. - Pregnancy: administer only if clearly indicated. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potassium chloride and glucose may interact with several medications.

Major Interactions (Avoid): - ACE inhibitors: can potentiate hyperkalemia. - Potassium‑sparing diuretics: increase risk of excessive potassium. - Insulin therapy: may cause rapid intracellular potassium shift.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may affect potassium homeostasis. - Digoxin: potassium level changes influence digoxin toxicity. - Loop diuretics: may cause potassium loss requiring dose adjustment.